1. Home
  2. APM vs NVVE Comparison

APM vs NVVE Comparison

Compare APM & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • NVVE
  • Stock Information
  • Founded
  • APM 2010
  • NVVE 1996
  • Country
  • APM United Kingdom
  • NVVE United States
  • Employees
  • APM N/A
  • NVVE N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • APM Health Care
  • NVVE Energy
  • Exchange
  • APM Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • APM 6.9M
  • NVVE 7.9M
  • IPO Year
  • APM 2018
  • NVVE N/A
  • Fundamental
  • Price
  • APM $1.42
  • NVVE $0.60
  • Analyst Decision
  • APM
  • NVVE
  • Analyst Count
  • APM 0
  • NVVE 0
  • Target Price
  • APM N/A
  • NVVE N/A
  • AVG Volume (30 Days)
  • APM 461.1K
  • NVVE 1.3M
  • Earning Date
  • APM 08-19-2025
  • NVVE 08-14-2025
  • Dividend Yield
  • APM N/A
  • NVVE N/A
  • EPS Growth
  • APM N/A
  • NVVE N/A
  • EPS
  • APM N/A
  • NVVE N/A
  • Revenue
  • APM N/A
  • NVVE $5,440,777.00
  • Revenue This Year
  • APM N/A
  • NVVE $892.33
  • Revenue Next Year
  • APM N/A
  • NVVE N/A
  • P/E Ratio
  • APM N/A
  • NVVE N/A
  • Revenue Growth
  • APM N/A
  • NVVE N/A
  • 52 Week Low
  • APM $0.46
  • NVVE $0.48
  • 52 Week High
  • APM $7.49
  • NVVE $8.76
  • Technical
  • Relative Strength Index (RSI)
  • APM 51.44
  • NVVE 39.80
  • Support Level
  • APM $1.21
  • NVVE $0.49
  • Resistance Level
  • APM $1.44
  • NVVE $0.63
  • Average True Range (ATR)
  • APM 0.13
  • NVVE 0.08
  • MACD
  • APM -0.04
  • NVVE 0.01
  • Stochastic Oscillator
  • APM 34.37
  • NVVE 38.79

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: